Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
HAYWARD, Calif., March 21, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn’s Chief Transformation Officer, will transition to a new role leading the company as Chief Executive Officer. Dunn succeeds Sanjay Banerjee, who is stepping down from his role as CEO.
